Geode Capital Management’s Aethlon Medical AEMD Stock Holding History

Geode Capital Management’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.4K	Buy	+24,364	New	+$55.4K	﹤0.01%	4294
2025 Q4	–	Sell	-1,347	Closed	-$10.1K	–	4473
2025 Q3	$10.1K	Hold	1,347	–	–	﹤0.01%	4446
2025 Q2	$16.2K	Sell	1,347 -206	-13%	-$5.53K	﹤0.01%	4386
2025 Q1	$44.5K	Buy	1,553 +174	+13%	+$8.1K	﹤0.01%	4222
2024 Q4	$94.9K	Buy	1,379 +149	+12%	+$5.06K	﹤0.01%	4108
2024 Q3	$45.9K	Buy	1,230 +977	+386%	+$31K	﹤0.01%	4277
2024 Q2	$10.1K	Hold	253	–	–	﹤0.01%	4546
2024 Q1	$34.1K	Hold	253	–	–	﹤0.01%	4397
2023 Q4	$44.4K	Hold	253	–	–	﹤0.01%	4377
2023 Q3	$42.8K	Buy	253 +41	+19%	+$10.5K	﹤0.01%	4455
2023 Q2	$61K	Hold	212	–	–	﹤0.01%	4461
2023 Q1	$65.2K	Hold	212	–	–	﹤0.01%	4457
2022 Q4	$46K	Hold	212	–	–	﹤0.01%	4607
2022 Q3	$98K	Hold	212	–	–	﹤0.01%	4584
2022 Q2	$190K	Buy	212 +6	+3%	+$5.59K	﹤0.01%	4297
2022 Q1	$240K	Hold	206	–	–	﹤0.01%	4287
2021 Q4	$306K	Buy	206 +35	+20%	+$79.7K	﹤0.01%	4285
2021 Q3	$526K	Buy	171 +42	+33%	+$141K	﹤0.01%	4009
2021 Q2	$507K	Buy	129 +46	+55%	+$106K	﹤0.01%	3938
2021 Q1	$135K	Hold	83	–	–	﹤0.01%	4228
2020 Q4	$164K	Buy	83 +61	+277%	+$81.5K	﹤0.01%	3937
2020 Q3	$23K	Hold	22	–	–	﹤0.01%	4112
2020 Q2	$35K	Buy	+22	New	+$26.6K	﹤0.01%	4029
2019 Q4	–	Sell	-11	Closed	-$29K	–	4208
2019 Q3	$29K	Hold	11	–	–	﹤0.01%	4113
2019 Q2	$46K	Hold	11	–	–	﹤0.01%	4088
2019 Q1	$120K	Buy	11 +6	+120%	+$85K	﹤0.01%	3854
2018 Q4	$102K	Hold	5	–	–	﹤0.01%	3852
2018 Q3	$73K	Hold	5	–	–	﹤0.01%	3978
2018 Q2	$79K	Buy	5 +3	+150%	+$47K	﹤0.01%	3916
2018 Q1	$28K	Hold	2	–	–	﹤0.01%	3998
2017 Q4	$27K	Hold	2	–	–	﹤0.01%	3982
2017 Q3	$37K	Hold	2	–	–	﹤0.01%	3967
2017 Q2	$51K	Hold	2	–	–	﹤0.01%	3955
2017 Q1	$78K	Hold	2	–	–	﹤0.01%	3870
2016 Q4	$101K	Hold	2	–	–	﹤0.01%	3791
2016 Q3	$120K	Hold	2	–	–	﹤0.01%	3763
2016 Q2	$138K	Hold	2	–	–	﹤0.01%	3704
2016 Q1	$133	Hold	2	–	–	﹤0.01%	3751
2015 Q4	$164K	Hold	2	–	–	﹤0.01%	3747
2015 Q3	$173K	Buy	+2	New	+$202K	﹤0.01%	3729

Other funds holding AEMD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's AEMD Position: Q1 2026 in Review

Geode Capital Management opened a new position in Aethlon Medical (AEMD) in Q1 2026: 24,364 shares worth $53.4K. The stake represents ﹤0.01% of the portfolio and ranks #4294 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in AEMD as recently as Q3 2025.

Geode Capital Management first reported a position in AEMD in Q3 2015 and has held it in 40 quarters since. The position peaked at $526K in Q3 2021. 12 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.

Geode Capital Management held 24,364 shares of Aethlon Medical worth $53.4K as of Q1 2026.
Aethlon Medical was a new Geode Capital Management position in Q1 2026.
Aethlon Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4294 holding.
Geode Capital Management first reported a position in Aethlon Medical in Q3 2015 and has held it in 40 quarters since.
Geode Capital Management's Aethlon Medical position peaked at $526K in Q3 2021.
12 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.